Krilogy Financial LLC Acelrx Pharmaceuticals Inc Transaction History

Krilogy Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.13 - $4.8 $639 - $1,440	-300 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$2.6 - $4.6 $780 - $1,380	300 New	300 $1,000
Q2 2018 Aug 15, 2018	SELL	$2.13 - $4.2 $639 - $1,260	-300 Closed	0 $0
Q3 2017 Nov 15, 2017	SELL	$2.9 - $4.6 $2,900 - $4,600	-1,000 Reduced 76.92%	300 $1,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,300	1,300 $3,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.